Acamprosate Calcium (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Acamprosate Calcium drug offered from Mylan Institutional Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | acamprosate calcium enteric-coated |
| SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-07-16 |
| END MARKETING DATE: | 0000-00-00 |
Acamprosate Calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acamprosate Calcium from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 333(mg/1) |
| START MARKETING DATE: | 2013-07-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-241_3bffa240-ca41-3bf6-e054-00144ff88e88 |
| PRODUCT NDC: | 51079-241 |
| APPLICATION NUMBER: | ANDA200142 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers:
